Pain Management in Patients with Liver, Kidney, and Heart Failure

First-Line Recommendation: Acetaminophen

The American Association for the Study of Liver Diseases recommends acetaminophen as the safest first-line analgesic for patients with combined liver disease, kidney failure, and heart failure, with a maximum dose of 3 grams per 24 hours 1, 2, 3
Acetaminophen is safe in heart failure patients without causing fluid retention or cardiac decompensation, as stated by the American Heart Association 2
The European Association for the Study of the Liver suggests that acetaminophen can be administered orally or intravenously 1

The American College of Cardiology states that NSAIDs are absolutely contraindicated in patients with liver, kidney, and heart failure due to multiple severe risks, including worsening congestive heart failure through fluid retention 4, 2
The American Heart Association warns that NSAIDs increase blood pressure by an average of 5 mm Hg 4
The National Kidney Foundation notes that NSAIDs cause acute renal failure, particularly in patients with pre-existing renal disease, heart failure, or cirrhosis 4

The American Geriatrics Society recommends that for moderate to severe pain uncontrolled by acetaminophen, opioids are the drugs of choice, with fentanyl, buprenorphine, or methadone being preferred in severely impaired renal function 1, 2
The European Society of Cardiology suggests that opioids require dose reduction in renal failure, and that morphine, oxycodone, hydromorphone, and tramadol should be used with caution 2

The American Family Physician recommends monitoring renal function, assessing for fluid retention and worsening heart failure, and evaluating for constipation when any analgesic is prescribed in this population 4, 1

The Journal of Hepatology suggests the following algorithm for pain management: mild pain - acetaminophen ≤3 g/day, moderate pain - acetaminophen + low-dose opioid, severe pain - full-dose opioid therapy with proactive bowel regimen 1, 2, 3